This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tezcan, H. Articles by Akalm, S. Search for Related Content PubMed PubMed Citation Articles by Tezcan, H. Articles by Akalm, S. Social Bookmarking                         What's this?

Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients

Department of Internal Medicine, Marmara University School of Medicine, haktezcan{at}hotmail.com

Dilek Yavuz

Department of Internal Medicine, Marmara University School of Medicine

Ahmet Toprak

Department of Internal Medicine, Marmara University School of Medicine

Ihsan Akpmar

Department of Radiology, Marmara University School of Medicine, Istanbul, Turkey

Mehmet Koç

Department of Internal Medicine, Marmara University School of Medicine

Oguzhan Deyneli

Department of Internal Medicine, Marmara University School of Medicine

Sema Akalm

Department of Internal Medicine, Marmara University School of Medicine

Introduction

Evidence suggests an association between insulin resistance, hypertension and impaired endothelial function. Studies have shown that insulin resistance precedes the development of hypertension. By improving insulin sensitivity, it may be possible to improve hypertension and the subsequent damage to vessel walls. Some data indicates beneficial effects of angiotensin-converting enzyme (ACE) inhibitors on insulin sensitivity and endothelial function. We aimed to investigate these effects of ACE inhibition in the same group of patients with essential hypertension.

Materials and methods

Nine non-smoking, untreated hypertensive patients (38.3 9 years, 4/5 male/female) and 12 age-matched healthy subjects (35.2 6.7 years, 5/7 male/female) were included in the study. Hypertensive patients were given enalapril maleate (5—40 mg/day) for six months. The following parameters were studied at baseline and at the end of treatment period. Whole body insulin sensitivity was measured by a formula derived from an oral glucose tolerance test and named I as the insulin sensitivity index (ISI). Insulin was measured by chemiluminescence and glucose by a glucose oxidase method. Endothelial function was evaluated as flow-mediated dilatation (FMD) of the brachial artery by ultrasonography and expressed as a percentage change relative to baseline diameter. Endothelialindependent vasodilatation was measured after sublingual nitroglycerine.

Results

FMD was impaired in the hypertensive group compared with healthy subjects (7.3 3.1% vs. 15.3 4.8%, p<0.0005), and ISI values were 1.18 0.6 vs. 4.4 0.9 (p<0.0001) respectively. Both insulin sensitivity and FMD improved after the treatment period compared with baseline values, FMD increased from 7.3 3.1% to 16.0 2.9% (p<0.0005) and ISI from 1.18 0.6 to 4.2 1.0 (p<0.0001). FMD and ISI showed a significant positive correlation (r=0.67, p<0.001) in the hypertensive group.

Conclusions

Patients with essential hypertension have impaired endothelial function and decreased whole body insulin sensitivity compared with healthy subjects. Treatment for six months with enalapril maleate seems to improve both FMD and ISI. This study confirms the beneficial effects of ACE inhibition on both endothelial function and insulin sensitivity tested in the same group of essential hypertensive patients. The mechanism of these favourable effects of ACE inhibition needs to be clarified.

Key Words: ACE inhibition • endothelial dysfunction • insulin sensitivity

Journal of Renin-Angiotensin-Aldosterone System, Vol. 4, No. 2, 119-123 (2003)
DOI: 10.3317/jraas.2003.012


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J.-C. Tardif Angiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery disease Eur. Heart J. Suppl., August 1, 2009; 11(suppl_E): E9 - E16. [Abstract] [Full Text] [PDF]